TRIBLE CITIZENS SCREENED UNDER ANAEMIA MISSION
Now writing the full study note.
Tribal Citizens Screened Under Anaemia Mission
1. At a Glance
- National Sickle Cell Anaemia Elimination Mission (NSCAEM) is India's flagship screening-cum-elimination programme for Sickle Cell Disease (SCD), targeted at tribal populations across 17 states, aiming to eliminate SCD as a public health problem by 2047 [S3].
- As of 16 July 2026, over 7.24 crore screenings have been conducted, identifying 2,47,961 diseased persons and 20,35,181 carriers [S1].
- Tests convergence of Ministry of Health & Family Welfare (nodal) and Ministry of Tribal Affairs (awareness/counselling) — a recurring UPSC trap on "who implements what" [S1][S3].
- High-yield for Prelims (numbers, launch facts) and Mains GS-II (health governance, tribal welfare) and GS-I (social justice/vulnerable groups).
2. Why in the News
- Union Minister for Tribal Affairs Shri Jual Oram informed the Rajya Sabha (22 July 2026) of updated NSCAEM screening data received from MoH&FW, reporting cumulative screening and diagnosis figures as on 16.07.2026 [S1].
3. Background & Evolution
- Union Budget 2023-24: NSCAEM first announced as a new mission [S3].
- 1 July 2023: Formally launched by PM Narendra Modi from Shahdol, Madhya Pradesh [S3].
- Designed as a sub-mission of the National Health Mission (NHM) [S6].
- Phased targets: universal screening of ~7 crore individuals aged 0–40 years across affected tribal areas by FY 2025-26 [S3][S6].
- Milestones: 1 crore screenings crossed (2023) [S4]; 6 crore screenings achieved milestone reported [S5]; 7.24 crore screenings as on 16.07.2026, the latest reported figure [S1].
- Predecessor context: SCD had earlier been flagged as a distinct tribal health burden in prior PIB releases on "Sickle Cell Disease" predating the mission's formal launch [S7].
4. Core Static Facts
| Item | Detail |
|---|---|
| Full name | National Sickle Cell Anaemia Elimination Mission (NSCAEM) [S3] |
| Launch date/place | 1 July 2023, Shahdol, Madhya Pradesh, by PM Modi [S3] |
| Parent scheme | Sub-mission under National Health Mission (NHM) [S6] |
| Nodal ministry | Ministry of Health & Family Welfare (MoH&FW) — technical/financial support to states [S1] |
| Supporting ministry | Ministry of Tribal Affairs — awareness generation & counselling material, especially in tribal areas [S6] |
| Target group | Age 0–40 years, in tribal-dominated areas [S1] |
| Geographic scope | 17 high-focus/tribal-dominated states: Gujarat, Maharashtra, Rajasthan, Madhya Pradesh, Jharkhand, Chhattisgarh, West Bengal, Odisha, Tamil Nadu, Telangana, Andhra Pradesh, Karnataka, Assam, Uttar Pradesh, Kerala, Bihar, Uttarakhand [S3] |
| Screening target | ~7 crore individuals by FY 2025-26 [S3][S6] |
| Screening venues | District Hospitals (DH) up to Ayushman Arogya Mandir (AAM) level [S1] |
| Data tracking | SCD Portal (state-reported) [S1] |
| Vision year | Eliminate SCD as public health problem by 2047 [S3] |
| Screenings (as on 16.07.2026) | >7.24 crore [S1] |
| Diseased identified | 2,47,961 [S1] |
| Carriers identified | 20,35,181 [S1] |
| Essential drug | Hydroxyurea, included in NHM Essential Drugs List [S1] |
| Worst-affected states | Odisha, Chhattisgarh, Madhya Pradesh (highest diseased + carrier counts) [S1] |
5. Multi-Dimensional Analysis
Social - SCD disproportionately affects Scheduled Tribe populations due to genetic prevalence patterns, making it a tribal-welfare and public-health equity issue simultaneously [S3]. - Carrier identification (20+ lakh) enables genetic counselling to prevent transmission — links to reproductive health and family planning outreach in tribal belts [S1].
Administrative - Classic Centre-State-tribal ministry convergence model: MoH&FW runs clinical screening; Ministry of Tribal Affairs handles IEC (information-education-communication); States report via a centralized SCD Portal [S1][S6]. - Screening infrastructure deliberately uses the lowest-tier health facility (AAM) to maximize last-mile reach in remote tribal areas [S1].
Governance - Real-time-ish tracking via a digital SCD Portal with state self-reporting builds a data-driven monitoring model, though data currently reflects state-reported figures without independent verification, a possible reliability caveat [S1].
Scientific/Public Health - SCD is a genetic haemoglobinopathy; the "diseased vs carrier" screening distinction reflects a population genetics elimination model akin to thalassemia control programmes, useful for cross-topic comparison in Mains answers [S1].
Economic - Long-run rationale: reducing disease burden in tribal workforce populations lowers healthcare cost burden and improves productivity in tribal-dominated states [S3].
6. Recent Developments (last 12-18 months)
- 6 crore screenings milestone reported under NSCAEM [S5].
- 22 July 2026: Rajya Sabha informed of 7.24 crore screenings, 2,47,961 diseased, 20,35,181 carriers identified (data as on 16.07.2026) [S1].
- World Sickle Cell Day observance events (e.g., AIIMS New Delhi) used to reinforce awareness push [S8].
7. Prelims Hooks
- NSCAEM launched by PM Modi on 1 July 2023 from Shahdol, Madhya Pradesh [S3].
- NSCAEM is a sub-mission of the National Health Mission (NHM), not a standalone scheme [S6].
- Target age group for screening: 0–40 years [S1].
- Screening covers 17 tribal-dominated/high-focus states [S3].
- Screening target: ~7 crore people by FY 2025-26 [S3].
- As on 16.07.2026: >7.24 crore screenings conducted [S1].
- 2,47,961 individuals identified as diseased with Sickle Cell Disease [S1].
- 20,35,181 individuals identified as carriers [S1].
- Nodal ministry for clinical implementation: Ministry of Health & Family Welfare, NOT Ministry of Tribal Affairs [S1].
- Ministry of Tribal Affairs' role: awareness generation and counselling material — not screening delivery [S6].
- Screening delivered from District Hospitals (DH) down to Ayushman Arogya Mandir (AAM) level [S1].
- Hydroxyurea is the key drug included in the NHM Essential Drugs List for SCD management [S1].
- Data reported via a dedicated SCD Portal [S1].
- Worst-affected states by diseased/carrier count: Odisha, Chhattisgarh, Madhya Pradesh [S1].
- NSCAEM's elimination target year: 2047 (aligned with "Viksit Bharat @2047" framing) [S3].
8. Mains Relevance
- GS-II: Government policies and interventions for development in health sector; issues relating to vulnerable sections (Scheduled Tribes) — "Welfare schemes for vulnerable sections of the population."
- GS-I: Salient features of Indian society — tribal population health vulnerabilities.
- GS-III (secondary): Health infrastructure and human resource development.
Plausible question stems: 1. "Discuss the significance of the National Sickle Cell Anaemia Elimination Mission in addressing genetic disease burden among India's tribal population. What are the institutional and implementation challenges it faces?" (GS-II) 2. "Sickle Cell Disease exemplifies the need for inter-ministerial convergence in tribal health governance. Elaborate with reference to NSCAEM." (GS-II) 3. "Examine the socio-economic implications of hereditary diseases like Sickle Cell Anaemia on tribal communities in India." (GS-I)
9. Related Topics to Study Next
- Ayushman Arogya Mandirs (AAM) — the last-mile health infrastructure used for NSCAEM screening.
- National Health Mission (NHM) — the parent umbrella scheme.
- Eklavya Model Residential Schools / tribal welfare architecture — broader Ministry of Tribal Affairs schemes.
- Thalassemia control programmes — comparative genetic-disorder elimination model.
- Scheduled Tribes health indicators (NFHS data) — baseline data context.
- PESA Act / Forest Rights Act — broader tribal governance framework (different ministry mandate, useful contrast).
- Ayushman Bharat–PM-JAY — health financing linkage for SCD patients.
- PVTG (Particularly Vulnerable Tribal Groups) welfare schemes — subset population often most affected.
10. Common Errors / Trap Areas
- Confusing NSCAEM as a Ministry of Tribal Affairs scheme — it is technically an NHM sub-mission under MoH&FW; Tribal Affairs only supports IEC/counselling [S1][S6].
- Mixing up the launch date/place (1 July 2023, Shahdol, MP) with other tribal health announcements.
- Confusing "diseased" vs "carrier" figures — carriers vastly outnumber diseased persons (~8:1 ratio) and are asymptomatic but transmission-relevant.
- Assuming the scheme covers all of India — it is restricted to 17 tribal-dominated states, not pan-India.
- Misremembering the target year as 2030 (common SDG-linked confusion) instead of the mission's own 2047 elimination vision.
11. Sources
- [S1] Tribal Citizens Screened Under Anaemia Mission — https://www.pib.gov.in/PressReleasePage.aspx?PRID=2287698 — (tier: 1)
- [S3] Prime Minister launches National Sickle Cell Anaemia Elimination Mission from Shahdol, Madhya Pradesh — https://www.pib.gov.in/PressReleasePage.aspx?PRID=1936735 — (tier: 1)
- [S4] Significant milestone crossed - more than 1 crore screened for Sickle Cell Disease under NSCAEM — https://www.pib.gov.in/PressReleasePage.aspx?PRID=1992340 — (tier: 1)
- [S5] India achieves Milestone of 6 Crore Screenings under National Sickle Cell Anemia Elimination Mission — https://www.pib.gov.in/PressReleasePage.aspx?PRID=2146906 — (tier: 1)
- [S6] Ministry of Tribal Affairs — role in NSCAEM — https://www.pib.gov.in/PressNoteDetails.aspx?NoteId=151898&ModuleId=3 — (tier: 1)
- [S7] Sickle Cell Disease — https://www.pib.gov.in/PressReleasePage.aspx?PRID=1896039 — (tier: 1)
- [S8] Observance of World Sickle Cell Day at AIIMS, New Delhi — https://www.pib.gov.in/PressReleasePage.aspx?PRID=2137717 — (tier: 1)